共 50 条
- [21] Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis TreatmentAMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (04) : 685 - 688Thomas, Sarah E.Seyger, Marieke M. B.Mangnus, Josje E.Otero, Marisol E.Gostynski, Antoni H.Njoo, Marcellus D.Ossenkoppele, Paul M.Haeck, Inge M.Hendricksen-Roelofzen, Judith H. J.Koerver, John E. M.Dodemont, Sharon R. P.Tupker, Ron A.Berends, Maartje A. M.Weppner-Parren, Lizelotte M. J. T.Keijsers, Romy R. M. C.Oostveen, Annet M.Peters, BasMommers, Rolandvan Doorn, Martijn B. A.Tjioe, MilanVeldkamp, Wendelien R.Kuijpers, Astrid L. A.Kleinpenning, Marloes M.de Jong, Elke M. G. J.van den Reek, Juul M. P. A.
- [22] Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of PsoriasisJOURNAL OF IMMUNOLOGY, 2018, 201 (06): : 1605 - 1613Hawkes, Jason E.Yan, Bernice Y.Chan, Tom C.Krueger, James G.
- [23] Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective studyAUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024,Koumprentziotis, Ioannis-AlexiosRompoti, NataliaStefanaki, IreneVavouli, CharitomeniPapoutsaki, MarinaPolitou, MariaStratigos, AlexanderNicolaidou, Electra
- [24] COMPARISON OF THE DRUG SURVIVAL OF INTERLEUKIN (IL)-17 AND IL-23 INHIBITORS FOR THE TREATMENT OF PSORIASIS: A TWO-CENTER STUDYACTA DERMATO-VENEREOLOGICA, 2024, 104Kang, Kyong-WonKang, Da-HyunKwon, Soon-HyoLew, Bark-LynnShin, Min KyungJeong, Ki-Heon
- [25] Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidenceDERMATOLOGY AND THERAPY, 2024, 14 (10) : 2739 - 2757Malagoli, PiergiorgioDapavo, PaoloAmerio, PaoloAtzori, LauraBalato, AnnaBardazzi, FedericoBianchi, LucaCattaneo, AngeloChiricozzi, AndreaCongedo, MaurizioFargnoli, Maria ConcettaGiofre, ClaudiaGisondi, PaoloGuarneri, ClaudioLembo, SerenaLoconsole, FrancescoMazzocchetti, GiampieroMercuri, Santo RaffaeleMorrone, PietroOffidani, Anna MariaPalazzo, GiovanniParodi, AuroraPellacani, GiovanniPiaserico, StefanoPotenza, ConcettaPrignano, FrancescaRomanelli, MarcoSavoia, PaolaStingeni, LucaTravaglini, MassimoTrovato, EmanueleVenturini, MarinaZichichi, LeonardoCostanzo, Antonio
- [26] The IL-23/Th17 pathway inhibitors in the treatment of psoriasis and the risk of skin malignancies: a reviewPOSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (06): : 552 - 559Krzysztofik, MartaBrzewski, PawelKulbat, AleksandraMasajada, MagdalenaRichter, KarolinaWysocki, Wojciech M.
- [27] Defining the effects of IL-23 inhibitors on local and systemic immune responses in psoriasisEUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1527 - 1527Mezghiche, IkramLeloup, ClaireDangien, AmbreYahia, HananeCamard, LaetitiaPietrosemoli, NataliaChica, ClaudiaFourie, AnneGreving, CarrieShaikh, Barbara JoyceParker, RaphaelleCua, Daniel J.Oules, BenedicteGuegan-Bart, SarahAractingi, SelimRogge, LarsBianchi, Elisabetta
- [28] Targeting IL-23 with Small Molecule Inhibitors: A New Horizon In Psoriasis TherapyCHEMISTRYSELECT, 2025, 10 (08):Sharbaji, RaghadSiyah, Pinar
- [29] Anti-drug antibodies of IL-23 inhibitors for psoriasis: a systematic reviewJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1171 - 1177Norden, A.Moon, J. Y.Javadi, S. S.Munawar, L.Maul, J-TWu, J. J.
- [30] IL-23 inhibitors in psoriasis, what are the effects on local and systemic immune responses?EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 199 - 199Mezghiche, I.Leloup, C.Dangien, A.Yahia-Cherbal, H.Camard, L.Pietrosemoli, N.Chica, C.Cua, D.Fourie, A.Greving, C.Shaikh, B.Parker, R.Oules, B.Guegan, S.Aractingi, S.Rogge, L.Bianchi, E.